Literature DB >> 186168

Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.

J H Joncas, E Rioux, J P Wastiaux, M Leyritz, L Robillard, J Menezes.   

Abstract

Two nasopharyngeal carcinomas of the lymphoepithelioma type and two Burkitt's lymphomas with the characteristic histopathologic features developed in three siblings and one first-degree cousin in a large French-Canadian family. Epstein-Barr virus antibody titres in the two lymphoepithelioma cases but not in the Burkitt's lymphoma cases were, as expected, greatly elevated. HLA typing of the family members failed to disclose HLA antigens A2 and B Sin-2, which have been associated with lymphoepithelioma in Asia. The occurrence, however, of a plasmacytoma in one other first-degree cousin and low serum IgA values in several siblings and cousins suggests the possibility of a genetically determined predisposing B-cell dysfunction in the development of these tumours.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186168      PMCID: PMC1879112     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians.

Authors:  H Betuel; M Camoun; J Colombani; N E Day; R Ellouz; G de-Thé
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

2.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

3.  Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis.

Authors:  G Henie; W Henle; C A Horwitz
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups.

Authors:  M J Simons; G B Wee; N E Day; P J Morris; K Shanmugaratnam; G B De-Thé
Journal:  Int J Cancer       Date:  1974-01-15       Impact factor: 7.396

6.  Nasopharyngeal carcinoma V: immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor.

Authors:  M J Simons; N E Day; G B Wee; K Shanmugaratnam; H C Ho; S H Wong; T K Ti; N K Yong; S Darmalingam; G De-Thé
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

7.  Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma.

Authors:  M J Simons; G B Wee; S H Chan; K Shanmugaratnam
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

8.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

  8 in total
  2 in total

Review 1.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

2.  Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.

Authors:  J H Joncas; A Wills; E Reece; Z Fox
Journal:  Can Med Assoc J       Date:  1981-10-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.